Apolipoprotein E and A-IV polymorphisms in ethnic Russians living in Estonia.

Genetika

Laboratory of Atherosclerosis Genetics, Center for Laboratory Medicine, Tampere University Hospital, P.O. Box 2000, FIN-33521 Tampere, Finland.

Published: September 2004

137 Russians living in Estonia was screened by isoelectric focusing and immunoblotting procedures to determine the distribution of genetic variations in apolipoprotein E (apoE) and apolipoprotein A-IV (apoA-IV) genes. The apoA-IV-2 allele and epsilon4 allele frequency of the Russians tended to be lower than in most other European populations.

Download full-text PDF

Source

Publication Analysis

Top Keywords

apolipoprotein a-iv
8
russians living
8
living estonia
8
a-iv polymorphisms
4
polymorphisms ethnic
4
ethnic russians
4
estonia 137
4
137 russians
4
estonia screened
4
screened isoelectric
4

Similar Publications

Background: Atherosclerotic cardiovascular disease (CVD) is a major cause of death in individuals with type 1 diabetes mellitus (T1DM). However, conventional risk factors do not fully account for the increased risk. This study aimed to investigate whether serum proteins associate with diabetes status and the occurrence of CVD in T1DM.

View Article and Find Full Text PDF

Clinicopathologic, Proteomic and Outcome Characteristics of Renal Apolipoprotein C-II Amyloidosis: A Case Series.

Am J Kidney Dis

November 2024

Department of Laboratory Medicine and Pathology, Rochester, Minnesota. Electronic address:

Article Synopsis
  • Amyloidosis derived from apolipoprotein C-II (AApoCII) is a rare condition that primarily affects the kidneys, presenting with symptoms like proteinuria and reduced kidney function, particularly in older patients.
  • A study conducted with 25 cases from the Mayo Clinic revealed common histological characteristics, such as nodular amyloid deposits in glomeruli, and proteomic analysis identified specific Apo C-II variants in many patients.
  • Despite significant kidney issues, including end-stage kidney disease in about half of the patients, the overall survival rate was more favorable, indicating potential for better outcomes in this condition.
View Article and Find Full Text PDF

Attenuation of high-fat diet-induced weight gain by apolipoprotein A4.

Obesity (Silver Spring)

December 2024

Department of Biomedical Sciences and Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.

Objective: Apolipoprotein A4 (APOA4) is synthesized by the small intestine in response to dietary lipids. Chronic exposure to a high-fat diet (HFD) desensitizes lipid-induced APOA4 production and attenuates brown adipose tissue (BAT) thermogenesis. We hypothesized that exogenous APOA4 could increase BAT thermogenesis and energy expenditure in HFD-fed mice, resulting in decreased obesity and improved glucose tolerance.

View Article and Find Full Text PDF

Milk Fat Globules: 2024 Updates.

Newborn (Clarksville)

March 2024

Global Newborn Society, Clarksville Maryland, United States of America.

Article Synopsis
  • * MFGs feature a unique structure with a lipid core and a membrane rich in bioactive components that aid in energy release and support immune health in developing gastrointestinal tracts.
  • * Research suggests MFGs can be enhanced to address specific nutritional deficiencies while also having potential therapeutic benefits for neurodevelopment and defense against infections.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!